EU: Falsified Medicines Directive 'Delegated Act' accepted by European Parliament.
作者信息
Price Richard
出版信息
Eur J Hosp Pharm. 2016 May;23(3):183-186. doi: 10.1136/ejhpharm-2016-000954.
Abstract
摘要
相似文献
1
EU: Falsified Medicines Directive 'Delegated Act' accepted by European Parliament.欧盟：欧洲议会通过《假药指令》“委托法案” 。
Eur J Hosp Pharm. 2016 May;23(3):183-186. doi: 10.1136/ejhpharm-2016-000954.
2
[securPharm e. V. - a protective shield against falsified medicines].[securPharm电子协会——防范假药的保护盾牌]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1255-1260. doi: 10.1007/s00103-017-2628-4.
3
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists.波兰的《欧洲假药指令》：背景、实施情况及对药剂师的潜在建议。
Eur J Hosp Pharm. 2018 Jan;25(1):10-15. doi: 10.1136/ejhpharm-2016-000970. Epub 2016 Jul 27.
4
5
Falsified Medicines-Bridging the Gap between Business and Public Health.假药——弥合商业与公共卫生之间的差距
Pharmacy (Basel). 2016 Mar 28;4(2):16. doi: 10.3390/pharmacy4020016.
6
EAHP President Joan Peppard advises members to heighten their awareness of the Falsified Medicines Directive in 2016.欧洲医院药剂师协会主席琼·佩珀德建议会员们提高对2016年《假药指令》的认识。
Eur J Hosp Pharm. 2016 Mar;23(2):124. doi: 10.1136/ejhpharm-2016-000910.
7
Falsified Medicines Directive in a Secondary Care Environment-Impact on Supply Chain.二级医疗环境中的《假药指令》——对供应链的影响
Int J Environ Res Public Health. 2022 Mar 10;19(6):3276. doi: 10.3390/ijerph19063276.
8
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.加强和合理化欧盟的药物警戒：欧洲将走向何方？对新的欧盟药物警戒立法的审查。
Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000.
9
[Falsified medicines in parallel trade].[平行贸易中的假药]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1208-1213. doi: 10.1007/s00103-017-2620-z.
10
Falsified Medicines Directive news: EDQM announce collaboration with the European Medicines Verification Organisation.《假药指令》新闻：欧洲药品质量管理局宣布与欧洲药品验证组织合作。
Eur J Hosp Pharm. 2016 Jan;23(1):61. doi: 10.1136/ejhpharm-2015-000851.
引用本文的文献
1
The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review.意外药物召回泛滥和心血管医学中伪造药物的大流行对患者安全和全球公共卫生构成威胁：简要综述。
Cardiol J. 2022;29(1):133-139. doi: 10.5603/CJ.a2020.0168. Epub 2020 Dec 21.
2
Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies' professionals in the European Economic Area.欧洲经济区制药公司专业人员对《假药指令》实施情况的认知。
Pharm Pract (Granada). 2017 Oct-Dec;15(4):1031. doi: 10.18549/PharmPract.2017.04.1031. Epub 2017 Dec 20.
Zotero 插件